Newsroom
Zhifei Attends 2023 World Lung Health Conference and Visits World Heal...
Zhifei Attends 2023 World Lung Health Conference and Visits World Health Organization
2023-12-27
From November 15th to 18th, the Union World Conference on Lung Health, the most prestigious academic conference in the field of global tuber...
see details 》
Zhifei and GSK reached strategic cooperation, adding a new blockbuster...
Zhifei and GSK reached strategic cooperation, adding a new blockbuster product
2023-10-12
On October 8, 2023, Chongqing Zhifei Biological Products Co., Ltd. (hereinafter referred to as "Zhifei") and GlaxoSmithKline (GSK Biologica...
Zhifei Longcom Recombinant COVID-19 Vaccine Receives Marketing Approva...
Zhifei Longcom Recombinant COVID-19 Vaccine Receives Marketing Approval in Kenya
2022-12-23
On December 22, the Company's Recombinant COVID-19 Vaccine (CHO Cell) was approved for marketing by the Pharmacy and Poisons Board (PPB) of...
Zhifei Attends 2023 World Lung Health Conference and Visits World Health Organization2023-12-27
Zhifei and GSK reached strategic cooperation, adding a new blockbuster product2023-10-12
Zhifei - Beijing R&D center expands to build innovative product incubation center2023-03-28
Based on the original technology platform of the R&D center in Beijing, Zhifei once again expands its R&D layout and builds an innovative p...
MSD and Zhifei Renew Collaboration on Vaccines2023-03-02
On January 21, 2023, through friendly negotiations between the two parties, Zhifei and MSD renewed the agreement on Supply, Distribution and...
Zhifei Longcom Recombinant COVID-19 Vaccine Receives Conditional Marketing Approval in Belarus2023-01-04
On January 3, local time, Zhifei longcom Recombinant COVID-19 Vaccine (CHO Cell) was approved for Conditional Marketing Approval by the Min...